PRKACA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.336100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.569790E-01
Normal-vs-Stage2
2.622000E-02
Normal-vs-Stage3
7.761500E-02
Normal-vs-Stage4
2.392500E-02
Stage1-vs-Stage2
3.715800E-01
Stage1-vs-Stage3
2.916200E-01
Stage1-vs-Stage4
4.557400E-01
Stage2-vs-Stage3
4.516400E-01
Stage2-vs-Stage4
9.474800E-01
Stage3-vs-Stage4
6.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.829800E-02
Normal-vs-AfricanAmerican
1.449020E-01
Normal-vs-Asian
4.681600E-02
Caucasian-vs-AfricanAmerican
8.654600E-01
Caucasian-vs-Asian
3.653000E-01
AfricanAmerican-vs-Asian
4.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.746300E-02
Normal-vs-Female
9.152400E-02
Male-vs-Female
5.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.805000E-01
Normal-vs-Age(41-60Yrs)
1.869200E-01
Normal-vs-Age(61-80Yrs)
4.925800E-02
Normal-vs-Age(81-100Yrs)
4.321800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.899600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.048600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.600760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.100000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.146100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.031740E-02
Normal-vs-Daily Drinker
8.050400E-02
Normal-vs-Weekly Drinker
8.393800E-02
Normal-vs-Occasional Drinker
2.109600E-01
Normal-vs-Social Drinker
3.872800E-01
Non Drinker-vs-Daily Drinker
4.338600E-01
Non Drinker-vs-Weekly Drinker
1.435850E-01
Non Drinker-vs-Occasional Drinker
6.938000E-02
Non Drinker-vs-Social Drinker
8.639600E-02
Daily Drinker-vs-Weekly Drinker
5.584600E-01
Daily Drinker-vs-Occasional Drinker
3.614800E-01
Daily Drinker-vs-Social Drinker
2.468200E-01
Weekly Drinker-vs-Occasional Drinker
7.457800E-01
Weekly Drinker-vs-Social Drinker
5.332800E-01
Occasional Drinker-vs-Social Drinker
7.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.266800E-01
Normal-vs-Grade 2
8.015400E-01
Normal-vs-Grade 3
8.544600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.883000E-01
Grade 1-vs-Grade 3
1.118250E-01
Grade 1-vs-Grade 4
4.266800E-01
Grade 2-vs-Grade 3
1.809620E-01
Grade 2-vs-Grade 4
8.015400E-01
Grade 3-vs-Grade 4
8.544600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.012200E-02
Normal-vs-NonDiabetic
9.929600E-02
Diabetic-vs-NonDiabetic
3.943600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.263900E-02
Normal-vs-NoPancreatitis
6.912300E-02
Pancreatitis-vs-NoPancreatitis
9.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.887980E-01
Normal-vs-N1
3.464200E-02
N0-vs-N1
3.312000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.201600E-03
Normal-vs-TP53-NonMutant
2.019200E-01
TP53-Mutant-vs-TP53-NonMutant
7.326100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
